Be 0 2 0 2 O
> 3 4 3 4 O
2 4 5 4 5 B-lower_bound
years 6 11 6 11 I-lower_bound
of 12 14 12 14 O
age 15 18 15 18 B-age
up 19 21 19 21 O
to 22 24 22 24 O
65 25 27 25 27 B-upper_bound
years 28 33 28 33 I-upper_bound
of 34 36 34 36 O
age 37 40 37 40 O

Diagnosis 0 9 41 50 O
of 10 12 51 53 O
significant 13 24 54 65 O
psychiatric 25 36 66 77 B-chronic_disease
disorder 37 45 78 86 I-chronic_disease
of 46 48 87 89 O
the 49 52 90 93 O
subject 53 60 94 101 O
that 61 65 102 106 O
could 66 71 107 112 O
seriously 72 81 113 122 O
impede 82 88 123 129 O
the 89 92 130 133 O
ability 93 100 134 141 O
to 101 103 142 144 O
participate 104 115 145 156 O
in 116 118 157 159 O
the 119 122 160 163 O
study 123 128 164 169 O

Have 0 4 170 174 O
a 5 6 175 176 O
diagnosis 7 16 177 186 O
of 17 19 187 189 O
SCD 20 23 190 193 B-chronic_disease
, 23 24 193 194 O
with 25 29 195 199 O
either 30 36 200 206 O
βS 37 39 207 209 O
/ 39 40 209 210 O
βS 40 42 210 212 O
, 42 43 212 213 O
βS 44 46 214 216 O
/ 46 47 216 217 O
βC 47 49 217 219 O
, 49 50 219 220 O
βS 51 53 221 223 O
/ 53 54 223 224 O
βD 54 56 224 226 O
, 57 58 227 228 O
βS 59 61 229 231 O
/ 61 62 231 232 O
β0 62 64 232 234 O
, 65 66 235 236 O
βS 67 69 237 239 O
/ 69 70 239 240 O
βO 70 72 240 242 O
- 72 73 242 243 O
Arab 73 77 243 247 O
, 77 78 247 248 O
or 79 81 249 251 O
βS 82 84 252 254 O
/ 84 85 254 255 O
β+ 85 87 255 257 O
genotype 88 96 258 266 O

Have 0 4 267 271 O
daily 5 10 272 277 B-technology_access
access 11 17 278 284 I-technology_access
to 18 20 285 287 I-technology_access
a 21 22 288 289 I-technology_access
smart 23 28 290 295 I-technology_access
phone 29 34 296 301 I-technology_access
, 34 35 301 302 I-technology_access
tablet 36 42 303 309 I-technology_access
, 42 43 309 310 I-technology_access
personal 44 52 311 319 I-technology_access
computer 53 61 320 328 I-technology_access
or 62 64 329 331 I-technology_access
other 65 70 332 337 I-technology_access
device 71 77 338 344 I-technology_access
capable 78 85 345 352 B-technology_access
of 86 88 353 355 I-technology_access
producing 89 98 356 365 I-technology_access
and 99 102 366 369 I-technology_access
transmitting 103 115 370 382 I-technology_access
videos 116 122 383 389 I-technology_access
over 123 127 390 394 I-technology_access
the 128 131 395 398 I-technology_access
internet 132 140 399 407 I-technology_access

Patient 0 7 408 415 O
is 8 10 416 418 O
on 11 13 419 421 O
liquid 14 20 422 428 O
form 21 25 429 433 O
of 26 28 434 436 O
Hydroxyurea 29 40 437 448 B-treatment
since 41 46 449 454 O
MPR 47 50 455 458 O

Patient 0 7 459 466 O
or 8 10 467 469 O
caregiver 11 20 470 479 O
refuses 21 28 480 487 O
Hydroxyurea 29 40 488 499 B-treatment

Patients 0 8 500 508 O
receiving 9 18 509 518 O
automatic 19 28 519 528 O
home 29 33 529 533 O
delivery 34 42 534 542 O
of 43 45 543 545 O
medications 46 57 546 557 B-treatment
since 58 63 558 563 O
medication 64 74 564 574 B-clinical_variable
possession 75 85 575 585 I-clinical_variable
ratio 86 91 586 591 I-clinical_variable
is 92 94 592 594 O
reflective 95 105 595 605 O
of 106 108 606 608 O
the 109 112 609 612 O
patient 113 120 613 620 O
initiation 121 131 621 631 O
the 132 135 632 635 O
refill 136 142 636 642 O
when 143 147 643 647 O
they 148 152 648 652 O
have 153 157 653 657 O
exhausted 158 167 658 667 O
the 168 171 668 671 O
home 172 176 672 676 O
supply 177 183 677 683 O
of 184 186 684 686 O
HU 187 189 687 689 O

Prescribed 0 10 690 700 O
Hydroxyurea 11 22 701 712 B-treatment
for 23 26 713 716 O
at 27 29 717 719 O
least 30 35 720 725 O
the 36 39 726 729 O
6 40 41 730 731 B-lower_bound
months 42 48 732 738 I-lower_bound
prior 49 54 739 744 I-lower_bound
to 55 57 745 747 O
study 58 63 748 753 O
entry 64 69 754 759 O

